Avastin has been shown to improve vision for a variety of retinal conditions. Avastin works by blocking the effects of vascular endothelial growth factor, or VEGF, a protein that causes abnormal blood vessels to grow and damage the macula. The macula is the part of the eye that is responsible for central reading vision. Avastin®Īvastin, also known as bevacizumab, is a medication that is also used to treat swelling in the macula due to wet age-related macular degeneration, vein occlusion, or diabetes. There are known side-effects in the use of Lucentis which include retinal detachment, increased intraocular pressure, intraocular inflammation, and infection.
Lucentis was designed specifically for use in the eye. By blocking VEGF, Lucentis aids in the prevention and reversal of vision loss experienced by patients with macular edema. Lucentis blocks the effects of vascular endothelial growth factor, or VEGF, a protein that causes abnormal blood vessels to grow and leak, damaging the macula. Now Lucentis is also used for swelling in the macula, or macular edema, which can occur from a vein occlusion or diabetes. Age-related macular degeneration affects the macula, the part of the eye that provides sharp, central vision.
Lucentis, also known as ranibizumab, is a medication that was initially used to treat the wet form of age-related macular degeneration since 2006. Lucentis, Avastin, Eylea, Jetrea, Triesence, Ozurdex, Iluvien Lucentis®
0 kommentar(er)
